All Relations between dopamine and 5-ht receptor 1a

Reference Sentence Publish Date Extraction Date Species
Akihiro Hasumi, Hideyuki Maed. Cannabidiol improves haloperidol-induced motor dysfunction in zebrafish: a comparative study with a dopamine activating drug. Journal of cannabis research vol 5 issue 1 2023 36871008 recent behavioral studies in rats have reported that cbd mediates serotonin (5-ht1a) receptor action to improve motor dysfunction induced by dopamine (d2) receptor blockade. 2023-03-04 2023-03-06 rat
Ho-Geun Kang, Hee-Yun Kim, Hyunwoo Jee, Hwanseok Jun, Hosong Cho, Dongjun Park, Hyun-Jong Ahn, Hyung-Min Kim, Hyun-Ja Jeon. Compound of Cynanchum wilfordii and Humulus lupulus L. Ameliorates Menopausal Symptoms in Ovariectomized Mice. Reproductive sciences (Thousand Oaks, Calif.) vol issue 2022 36333646 values for hypothalamic serotonin (5-ht), dopamine, norepinephrine, estrogen receptor (er)-\xce\xb2, 5-ht1a, and 5-ht2a were significantly enhanced, while value for hypothalamic monoamine oxidase a was reduced in cwhl and caudatin groups compared with the ovx group. 2022-11-05 2023-01-30 mouse
Noelia Cantero-Garc\\xc3\\xada, Antonio Flores-Burgess, Juan Pedro Pineda-G\\xc3\\xb3mez, Laura Orio, Antonia Serrano, Zaida D\\xc3\\xadaz-Cabiale, Carmelo Mill\\xc3\\xb3. Galanin N-terminal fragment (1-15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol 153 issue 2022 36076594 we have analysed the transcriptional changes of c-fos, dopamine receptors, gal receptors and 5ht1a receptors in the corticomesolimbic system. 2022-09-09 2023-01-30 rat
Noelia Cantero-Garc\\xc3\\xada, Antonio Flores-Burgess, Juan Pedro Pineda-G\\xc3\\xb3mez, Laura Orio, Antonia Serrano, Zaida D\\xc3\\xadaz-Cabiale, Carmelo Mill\\xc3\\xb3. Galanin N-terminal fragment (1-15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol 153 issue 2022 36076594 notably, the mechanism of gal(1-15)-mediated actions involved changes in c-fos, dopamine receptors and 5ht1a expression in the ventral tegmental area, accumbens nucleus and prefrontal cortex. 2022-09-09 2023-01-30 rat
Emanuela Dyrmishi, Marco De Pieri, Marco Ferrari, Rafael Traber, Matteo Preve, Luca De Peri, Emilio Boll. Case Report: Long-Acting Oral Cariprazine. Frontiers in psychiatry vol 13 issue 2022 35573352 cariprazine is a partial agonist at dopamine receptors d2 and d3 and serotonin receptor 5ht1a and an antagonist at serotonin receptors 5ht2b and 5ht2a. 2022-05-16 2023-01-27 Not clear
Yasuhiro Kyono, Lori Ellezian, YueYue Hu, Kanella Eliadis, Junlone Moy, Elizabeth B Hirsch, Michael J Federle, Stephanie A Flower. The Atypical Antipsychotic Quetiapine Promotes Multiple Antibiotic Resistance in Escherichia coli. Journal of bacteriology vol issue 2022 35416690 while aaps primarily target dopamine (d2) and serotonin (5ht2a and 5ht1a) receptors, they also exhibit intrinsic antimicrobial activity as an off-target effect. 2022-04-13 2023-01-27 Not clear
Ashish Patel, Arya Patel, Darshini Patel, Krina Patel, Tushar Bambharoliy. Mini Review on Cariprazine: A Promising Antipsychotic Agent. CNS & neurological disorders drug targets vol issue 2022 35331126 however, due to the partial agonist action on dopamine d2, d3 receptors, and serotonin 5-ht1a receptors as well as antagonist effect on 5-ht2a, 5-ht2b, and h1 receptors, cariprazine differentiate pharmacologically from other apds, both typical and atypical. 2022-03-25 2023-01-27 Not clear
Mauricio Tohe. Cariprazine as a Treatment Option for Depressive Episodes Associated with Bipolar 1 Disorder in Adults: An Evidence-Based Review of Recent Data. Drug design, development and therapy vol 15 issue 2021 34012253 cariprazine, a broad-spectrum dopamine antagonist/partial agonist with dopamine d3/d2 (preferring d3) and serotonin 5-ht1a receptor partial agonist properties, was recently approved. 2021-11-23 2023-01-26 Not clear
Speranta Avram, Miruna Silvia Stan, Ana Maria Udrea, C\\xc4\\x83t\\xc4\\x83lin Buiu, Anca Andreea Boboc, Maria Merne. 3D-ALMOND-QSAR Models to Predict the Antidepressant Effect of Some Natural Compounds. Pharmaceutics vol 13 issue 9 2021 34575524 their antidepressant and neuroleptic activities were predicted by 3d-almond-qsar models built by considering three important targets, namely serotonin transporter (sert), 5-hydroxytryptamine receptor 1a (5-ht1a), and dopamine d2 receptor. 2021-10-01 2023-01-26 Not clear
Francesca Calabrese, Frank I Tarazi, Giorgio Racagni, Marco A Riv. The role of dopamine D CNS spectrums vol 25 issue 3 2021 31010452 specifically, cariprazine acts as a partial agonist at the dopamine (da) d2 and d3 receptors and serotonin 5-ht1a receptors, and as an antagonist at the 5-ht2b receptors. 2021-08-24 2023-01-26 Not clear
Nicholas Keks, Judith Hope, Darren Schwartz, Harold McLennan, David Copolov, Graham Meadow. Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia. CNS drugs vol 34 issue 5 2021 32246399 in contrast to aripiprazole, brexpiprazole has lower intrinsic dopamine d2 activity and higher affinity for the serotonin 5-ht1a and 5-ht2a receptors, while cariprazine has the highest affinity for the dopamine d3 receptor, and the longest half-life. 2021-08-05 2023-01-26 Not clear
Roger S Mcintyre, Eduard Vieta, Willie Earley, Mehul Pate. Effects of\\xc2\\xa0Cariprazine\\xc2\\xa0on Cognition in Patients\\xc2\\xa0With\\xc2\\xa0Bipolar Mania or Mixed States: Post Hoc Analysis From 3 Randomized, Controlled Phase III Studies. CNS spectrums vol 26 issue 2 2021 34127095 cariprazine, a dopamine d3-preferring d3/d2 and serotonin 5-ht1a receptor partial agonist, is approved for the treatment of schizophrenia and for depressive, manic, or mixed episodes associated with bipolar i disorder. 2021-07-23 2023-01-26 Not clear
Raheel Saeed, Khalid Mahmood, Sadia Basharat Ali, Darakhshan Jabeen Halee. Prevention of diet restriction induced hyperactivity but not body-weight reduction in rats co-treated with tryptophan: relationship with striatal serotonin and dopamine metabolism and serotonin-1A auto-receptor expression. Nutritional neuroscience vol issue 2021 33722185 the study suggests that the striatal metabolism of 5-ht and dopamine and mrna expression of 5-ht1a auto-receptor has an important role in the pathogenesis of an. 2021-05-18 2023-01-26 rat
Rosaria Nardello, Fulvio Guccione, Claudia Gliubizzi, Antonio Marino, Mariarita Capizzi, Salvatore Mangan. Resolution of enuresis with aripiprazole in children with psychiatric disorders: two case reports. Journal of medical case reports vol 15 issue 1 2021 33883037 as partial agonist of the dopamine (d2) and serotonin (5-ht1a) receptors, it appears to be effective in reducing mania in patients with bipolar disorder, tics in tourette syndrome, aggression in schizophrenia and autism spectrum disorder. 2021-05-14 2023-01-26 Not clear
Matheus Libarino-Santos, Ana Catherine Gomes de Santana Santos, Elisangela G Cata-Preta, Tha\\xc3\\xadsa Barros-Santos, Nina Rosa Nunes Brand\\xc3\\xa3o, Aurea Lorena Nunes Borges, Renan Santos-Baldaia, Andr\\xc3\\xa9 W Hollais, Marilia A Baldaia, La\\xc3\\xads F Berro, Eduardo A V Marinho, Roberto Frussa-Filho, Alexandre J Oliveira-Lim. Role of the treatment environment in the effects of aripiprazole on ethanol-induced behavioral sensitization and conditioned place preference in female mice. Drug and alcohol dependence vol 208 issue 2021 31954952 evidence suggests that aripiprazole, a partial dopamine d2 and serotonin 5-ht1a receptor agonist and 5-ht2a receptor antagonist, show significant efficacy in reducing alcohol use. 2021-01-18 2023-01-26 mouse
Nami Isooka, Ikuko Miyazaki, Ryo Kikuoka, Kouichi Wada, Erika Nakayama, Kotaro Shin, Daichi Yamamoto, Yoshihisa Kitamura, Masato Asanum. Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes. Neurochemistry international vol 132 issue 2021 31765686 rotigotine, an anti-parkinsonian drug, can bind to dopamine and 5-ht1a receptors. 2021-01-07 2023-01-26 Not clear
Chara A Zika, Ioannis Nicolaou, Antonis Gavalas, George V Rekatas, Ekaterini Tani, Vassilis J Demopoulo. Behavioral and antioxidant activity of a tosylbenz[g]indolamine derivative. A proposed better profile for a potential antipsychotic agent. Annals of general hospital psychiatry vol 3 issue 1 2020 14711381 in a previous study we have shown that an indolamine molecule expresses a moderate binding affinity at the dopamine d2 and serotonin 5-ht1a receptors in in vitro competition binding assays. 2020-09-30 2023-01-24 rat
Lakshmi N Yatham, Eduard Vieta, Roger S McIntyre, Rakesh Jain, Mehul Patel, Willie Earle. Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications. The primary care companion for CNS disorders vol 22 issue 5 2020 32942346 cariprazine, a dopamine d\xe2\x82\x83-preferring d\xe2\x82\x83/d\xe2\x82\x82 receptor partial agonist with serotonin 5-ht1a receptor partial agonist and serotonin 5-ht2a antagonist properties, is approved to treat manic and depressive episodes of bipolar disorder. 2020-09-29 2023-01-26 Not clear
Shrikant S Kolan, Tommy Lidstr\\xc3\\xb6m, Tom\\xc3\\xa1s Mediavilla, Andy Dernstedt, Sofie Degerman, Magnus Hultdin, Karl Bj\\xc3\\xb6rk, Daniel Marcellino, Mattias N E Forsel. Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling. Scientific reports vol 9 issue 1 2020 30862884 neurotransmitters such as serotonin and dopamine influence activation of b cells and the effects of a selective serotonin 1a receptor (5ht1a) antagonist on growth of a number of b cell-derived lymphoma cell lines were investigated. 2020-09-28 2023-01-26 human
L\\xc3\\xadgia Castanheira, Elsa Fernandes, Pedro Levy, Ricardo Coentr. Aripiprazole-induced Hepatitis: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol 17 issue 4 2020 31671495 aripiprazole is an atypical antipsychotic that acts as a partial agonist of dopamine type 2 receptors as well as 5-ht1a receptors. 2020-09-28 2023-01-26 Not clear